Splash Beverage expands CannEpil license to veterinary therapeutics in 8-K amendment

Reuters2026/07/30 20:12

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Splash Beverage Group amended a Form 8-K to reflect an expanded exclusive global CannEpil license covering veterinary therapeutics.
Added rights cover worldwide development, manufacturing, commercialization, marketing, distribution for veterinary diseases, creating a second FDA-regulated program.
Initial veterinary focus targets companion-animal oncology, chronic pain; plans FDA CVM pathways including INAD, Conditional Approval.
Amendment sets a 10% royalty on net revenues from veterinary CannEpil applications payable to Argent BioPharma.
Strategic joint venture under finalization with a cannabinoid pharmaceutical partner to lead veterinary development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Splash Beverage Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001731122-26-000990), on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Splash Beverage expands CannEpil license to veterinary therapeutics in 8-K amendment

You may also like

Crypto prices